A Single Center, Randomized, Parallel Groups, Placebo-Controlled Study Comparing The Efficacy, Safety, And Tolerability Of The Daily Co-administration Of Ezetimibe 10 Mg Or Ezetimibe Placebo To Ongoing Treatment With Atorvastatin 10 Mg In Subjects With Primary Hypercholesterolemia And Multiple Coronary Heart Disease Risk Factors in Indonesian Population.
Phase of Trial: Phase IV
Latest Information Update: 06 Nov 2013
At a glance
- Drugs Atorvastatin; Ezetimibe
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Merck & Co
- 09 May 2011 Actual end date (Oct 2006) added as reported by ClinicalTrials.gov.
- 02 Feb 2007 Status changed from recruiting to in progress.
- 21 Jul 2006 New trial record.